Ahmed S A, Ruvinov S B, Kayastha A M, Miles E W
Laboratory of Biochemical Pharmacology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
J Biol Chem. 1991 Nov 15;266(32):21548-57.
The origin of reaction and substrate specificity and the control of activity by protein-protein interaction are investigated using the tryptophan synthase alpha 2 beta 2 complex from Salmonella typhimurium. We have compared some spectroscopic and kinetic properties of the wild type beta subunit and five mutant forms of the beta subunit that have altered catalytic properties. These mutant enzymes, which were engineered by site-directed mutagenesis, have single amino acid replacements in either the active site or in the wall of a tunnel that extends from the active site of the alpha subunit to the active site of the beta subunit in the alpha 2 beta 2 complex. We find that the mutant alpha 2 beta 2 complexes have altered reaction and substrate specificity in beta-elimination and beta-replacement reactions with L-serine and with beta-chloro-L-alanine. Moreover, the mutant enzymes, unlike the wild type alpha 2 beta 2 complex, undergo irreversible substrate-induced inactivation. The mechanism of inactivation appears to be analogous to that first demonstrated by Metzler's group for inhibition of two other pyridoxal phosphate enzymes. Alkaline treatment of the inactivated enzyme yields apoenzyme and a previously described pyridoxal phosphate derivative. We demonstrate for the first time that enzymatic activity can be recovered by addition of pyridoxal phosphate following alkaline treatment. We conclude that the wild type and mutant alpha 2 beta 2 complexes differ in the way they process the amino acrylate intermediate. We suggest that the wild type beta subunit undergoes a conformational change upon association with the alpha subunit that alters the reaction specificity and that the mutant beta subunits do not undergo the same conformational change upon subunit association.
利用鼠伤寒沙门氏菌的色氨酸合成酶α2β2复合物,研究了反应和底物特异性的起源以及通过蛋白质-蛋白质相互作用对活性的控制。我们比较了野生型β亚基和五种具有改变催化特性的β亚基突变形式的一些光谱和动力学性质。这些通过定点诱变工程改造的突变酶,在α2β2复合物中,活性位点或从α亚基活性位点延伸至β亚基活性位点的通道壁上有单个氨基酸替换。我们发现,突变的α2β2复合物在与L-丝氨酸和β-氯-L-丙氨酸的β-消除和β-取代反应中,反应和底物特异性发生了改变。此外,与野生型α2β2复合物不同,突变酶会发生不可逆的底物诱导失活。失活机制似乎类似于Metzler小组首次证明的另外两种磷酸吡哆醛酶的抑制机制。对失活酶进行碱性处理可产生脱辅基酶和一种先前描述的磷酸吡哆醛衍生物。我们首次证明,碱性处理后添加磷酸吡哆醛可恢复酶活性。我们得出结论,野生型和突变型α2β2复合物在处理氨基丙烯酸酯中间体的方式上存在差异。我们认为,野生型β亚基与α亚基结合时会发生构象变化,从而改变反应特异性,而突变型β亚基在亚基结合时不会发生相同的构象变化。